Near-real time data access provides integrated views of the patient journey and clinical practice, enabling life sciences organizations to gain deep insights.
Heart attack and stroke are 2 of the top 10 causes of death worldwide. Identifying the proteins involved in each of them is the beginning of a journey to understanding how these diseases develop. In a novel experiment presented at the American Heart Association Scientific Sessions on November 12, 2017, and published in a supplement […]
In this brief, we share insights on challenges in managing outcomes-based contracts (OBCs) with health plans today and solutions to address these challenges, based on our conversations with more than a dozen life sciences companies.
In today’s healthcare system, we are not getting the value for the costs we are spending. It’s a complex issue with an equally complex set of potential solutions. But as the industry shifts to value-based care, we’ve reached a tipping point.
Innovation, by its nature is new, and having never been done before, is hard. To do something for the first time takes much more effort and concentration than when there is muscle memory, a process, precedent to follow. To do something innovative with multi stakeholder input – provider, pharma, technology – adds another dimension of […]
Almost exactly 2 years ago at HIMSS we announced Watson Health, a separate business unit within IBM, focused on impacting health through the power of cognitive and analytics. Two years ago the announcement was full of possibility. Today we can share positivity, and evidence of success. In forming Watson Health we created a technology platform […]
Learn how Watson Health & Celgene are working to uncover new approaches to patient safety. Ed Mingle, the global head of Safety Operations at Celgene corporation, discusses how the possibilities of future care are endless with the power of cognitive solutions.
Learn how Watson Health is helping researchers advance the fight against rare diseases. In this video, Dr. Robert Bowser from the Barrow Neurological Institute explains how Watson Health is helping transform the world of drug discovery.
The increasing pressures faced by life sciences companies and the rise of big data have led to a new approach for the generation of medical evidence in recent years: mining longitudinal electronic medical records (EMRs).
Watson Health and Pfizer Inc. today announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer’s research in immuno-oncology, an approach to cancer treatment that uses the body’s immune system to help fight cancer.
Leaders in healthcare and technology are often working to pinpoint ways to better meet the needs of those they serve. In the healthcare and technology sectors, both of which are undergoing immense transformations, there are several trends that are disrupting the way we do business – but are also presenting unprecedented opportunities.